Patient experience and use of an intervention combining nurse-led telephone and technologies for the monitoring of oral cancer medication

Abstract

Background: CAPRI, a randomized phase III trial comparing: an intervention combining Nurse Navigators (NNs) and a mobile application vs. Standard of care in cancer patients treated with oral anticancer agents was initiated in 2016 at Gustave Roussy (Villejuif, France). NNs provide regular telephone follow‐ups to manage patients' symptoms and assess toxicities, adherence to treatment and supportive care needs. Patients have access to a mobile application to record tracking data, contact NNs via secure messaging, view therapy and side effect information or store documents. Patient can contact the NNs on a dedicated phone line or by email/secure messaging Methods: The present analysis involves 3 main data sources: ‐ A questionnaire sent to patients after using for 5 months the CAPRI intervention in order to assess their experience, ‐ Interviews conducted with patients to obtain their feedback of the intervention, ‐ Data extraction from the application and NNs' interventions over a 24‐month period. Results: Overall, 166 patients (83%) filled the questionnaire. Fifteen interviews were conducted. Patients' experience with CAPRI intervention is summarized in the table below. (Table Presented) .